Latest News
Oct 26, 2017
Microbiotica to Participate in Microbiome Panel at BIO-Europe®

Cambridge, UK, 25th October 2017 – Microbiotica, a leading player in microbiome-based therapeutics, today announces that Nigel Crockett, Head of Business Development, will participate in the...

Oct 11, 2017
Microbiotica Celebrates Successful First Year with Third Award Win

Company receives ‘Best Start-up Biotech’ at OBN Awards

Cambridge, UK, 11 October 2017 – Microbiotica, a leading player in microbiome-based...

Sep 18, 2017
Microbiotica Wins Biotech and Money’s ‘Life Science Spin-out of the Year’

Cambridge, UK, 18 September 2017 – Microbiotica, a leading player in microbiome-based therapeutics, announces that it was chosen as the winner of the ‘Life Science Spin-out of the...

Sep 18, 2017
Microbiotica to Present at Leading Microbiome Summit

Cambridge, UK, 18 September 2017 – Microbiotica, a leading player in microbiome-based therapeutics, today announces that CEO, Dr Mike Romanos, will present at the Annual Microbiome Summit:...

Aug 9, 2017
Microbiotica Shortlisted for 2017 OBN Awards ‘Best Start-up Biotech Company’

Cambridge, UK, 9 August 2017 - Microbiotica, a leading player in microbiome-based therapeutics, is delighted to be announced that it has been selected as a finalist in the ‘Best Start-up...

Jul 13, 2017
Microbiotica Wins One Nucleus Summer BioNewsRound Award

Cambridge, UK, 13 July 2017 – Microbiotica, a leading player in microbiome-based therapeutics, is pleased to announce that it was voted as the winner of the Summer 2017 BioNewsRound Award at...

Jun 26, 2017
Microbiotica Shortlisted for Biotech and Money’s ‘Life Science Spin-out of the Year’

Cambridge, UK, 26 June 2017

Microbiotica, a leading player in microbiome-based therapeutics, is delighted to announce that it has been shortlisted for the ‘Life Science Spin-out of...

Jun 20, 2017
Microbiotica to Present at Microbiome Drug Development Summit

27-29 June 2017, Boston

Cambridge, UK, 20 June 2017 – Microbiotica, a leading player in microbiome-based therapeutics, announces that its Chief Scientific Officer Dr Trevor Lawley...

May 9, 2017
Microbiotica Appoints John Shields as Non-Executive Director

Microbiotica, the spin-out company from the UK’s Wellcome Trust Sanger Institute (Sanger Institute), is pleased to announce the appointment of Dr John Shields as a non-executive...

Dec 19, 2016
Cambridge Innovation Capital plc and IP Group plc announce the creation of Wellcome Trust Sanger Institute spin-out company, Microbiotica

Based on ground-breaking research at the Wellcome Trust Sanger Institute into the role of the human microbiome in disease

Goal is to create the world’s leading company focused on microbiome biology...


 Contacts:

Microbiotica

 Instinctif Partners

 (media enquiries)

Rowena Gardner

Sue Charles / Gemma Harris

E: rgardner@microbiotica.com

E: microbiotica@instinctif.com

T: +44 (0) 1223 786063

T: + 44 (0) 20 7866 7860

 

Upcoming Events
Microbiome Invest
May 23, 2018
London
More Information
Microbiome Drug Development
Jun 20 to Jun 22, 2018
Boston
More Information
Past Events
Microbiome Drug Development Summit Paris 2018
Jan 29 to Jan 31, 2018
Paris
Norwich Research Park Leadership Session at Genesis 2017- Collaborating with the Microbiome
Dec 14, 2017
London